Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call
Solésence (OTCQB: NANX), a healthcare solutions provider specializing in beauty and life science categories, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement. The company will release results after market close on Wednesday, March 26, 2025, followed by a conference call and webcast on Thursday, March 27, 2025 at 7:00 a.m. CDT (8:00 a.m. EDT).
The conference call will feature presentations from President & CEO Jess Jankowski and COO Kevin Cureton. Investors can access the webcast through the company's investor relations website or register for the dial-in option.
Solésence (OTCQB: NANX), un fornitore di soluzioni sanitarie specializzato nelle categorie di bellezza e scienze della vita, ha programmato l'annuncio dei risultati finanziari del Quarto Trimestre e dell'Anno Completo 2024. L'azienda rilascerà i risultati dopo la chiusura del mercato mercoledì 26 marzo 2025, seguito da una conferenza telefonica e una diretta web giovedì 27 marzo 2025 alle 7:00 CDT (8:00 EDT).
La conferenza telefonica presenterà interventi del Presidente e CEO Jess Jankowski e del COO Kevin Cureton. Gli investitori possono accedere alla diretta web tramite il sito web delle relazioni con gli investitori dell'azienda o registrarsi per l'opzione di chiamata.
Solésence (OTCQB: NANX), un proveedor de soluciones de salud especializado en las categorías de belleza y ciencias de la vida, ha programado el anuncio de sus resultados financieros del Cuarto Trimestre y del Año Completo 2024. La compañía publicará los resultados después del cierre del mercado el miércoles 26 de marzo de 2025, seguido de una llamada de conferencia y una transmisión en vivo el jueves 27 de marzo de 2025 a las 7:00 a.m. CDT (8:00 a.m. EDT).
La llamada de conferencia contará con presentaciones del Presidente y CEO Jess Jankowski y del COO Kevin Cureton. Los inversores pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de la empresa o registrarse para la opción de llamada.
솔레센스 (OTCQB: NANX), 뷰티 및 생명 과학 분야에 전문화된 헬스케어 솔루션 제공업체가 2024년 4분기 및 연간 실적 발표를 예정하고 있습니다. 회사는 2025년 3월 26일 수요일 시장 마감 후 실적을 발표하며, 2025년 3월 27일 목요일 오전 7시 CDT (오전 8시 EDT)에 컨퍼런스 콜 및 웹캐스트를 진행할 예정입니다.
컨퍼런스 콜에서는 사장 겸 CEO인 제스 얀코프스키와 COO인 케빈 큐어턴의 발표가 있을 것입니다. 투자자들은 회사의 투자자 관계 웹사이트를 통해 웹캐스트에 접속하거나 전화 참여 옵션에 등록할 수 있습니다.
Solésence (OTCQB: NANX), un fournisseur de solutions de santé spécialisé dans les catégories de beauté et de sciences de la vie, a programmé l'annonce de ses résultats financiers pour le quatrième trimestre et l'année complète 2024. L'entreprise publiera les résultats après la fermeture du marché le mercredi 26 mars 2025, suivi d'une conférence téléphonique et d'un webinaire le jeudi 27 mars 2025 à 7h00 CDT (8h00 EDT).
La conférence téléphonique comprendra des présentations du président et PDG Jess Jankowski et du COO Kevin Cureton. Les investisseurs peuvent accéder au webinaire via le site web des relations investisseurs de l'entreprise ou s'inscrire pour l'option d'appel.
Solésence (OTCQB: NANX), ein Anbieter von Gesundheitslösungen, der sich auf die Bereiche Schönheit und Lebenswissenschaften spezialisiert hat, hat die Ankündigung seiner finanziellen Ergebnisse für das 4. Quartal und das Gesamtjahr 2024 geplant. Das Unternehmen wird die Ergebnisse nach Börsenschluss am Mittwoch, den 26. März 2025 veröffentlichen, gefolgt von einer Telefonkonferenz und einem Webcast am Donnerstag, den 27. März 2025 um 7:00 Uhr CDT (8:00 Uhr EDT).
Die Telefonkonferenz wird Präsentationen von Präsident und CEO Jess Jankowski sowie COO Kevin Cureton beinhalten. Investoren können über die Investor-Relations-Website des Unternehmens auf den Webcast zugreifen oder sich für die Telefonoption registrieren.
- None.
- None.
ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2024 after the market close on Wednesday, March 26, 2025, and host a conference call and webcast on Thursday, March 27.
Fourth Quarter 2024 Conference Call Details
Date / Time: Thursday, March 27, 2025 - 7:00 a.m. CDT, 8:00 a.m. EDT
Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer
Webcast Link: https://edge.media-server.com/mmc/p/5vfh7m2x
Dial-In Link: https://register-conf.media-server.com/register/BIcd1760ffa58444b1967f8887796d1b08
To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.
The call may also be accessed through the company’s investor relations website, at https://ir.solesence.com/. Please join the conference call at least five minutes before prior to the start time.
About Solésence, Inc.
Solésence, Inc. (OTCQB: NANX), is a leader in scientifically-driven health care solutions across beauty and life science categories. With a mission to deliver joy through innovation, inclusivity and the science of beautiful skin, we have redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability — empowering individuals to embrace beauty on their own terms. Combining best-in-class skin health solutions with the celebration of self-care, we allow brands to deliver unique product claims and attributes by seamlessly integrating protection, prevention, and treatment technologies into daily use products. Learn more at solesence.com.
Media Contact:
Investor Relations Contact:
(630) 771-6736
FAQ
When will Solésence (NANX) release its Q4 and Full Year 2024 earnings?
What time is Solésence's (NANX) Q4 2024 earnings conference call?
Who will be speaking at Solésence's (NANX) Q4 2024 earnings call?
How can investors access Solésence's (NANX) Q4 2024 earnings call?
